Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Timing of nicotine lozenge administration to minimize trigger induced craving and withdrawal symptoms.

Kotlyar M, Lindgren BR, Vuchetich JP, Le C, Mills AM, Amiot E, Hatsukami DK.

Addict Behav. 2017 Aug;71:18-24. doi: 10.1016/j.addbeh.2017.02.018. Epub 2017 Feb 10.

PMID:
28235705
2.

Relationship of nicotine deprivation and indices of alcohol use behavior to implicit alcohol and cigarette approach cognitions in smokers.

Cohn A, Ehlke S, Cobb CO.

Addict Behav. 2017 Apr;67:58-65. doi: 10.1016/j.addbeh.2016.12.004. Epub 2016 Dec 9.

PMID:
28038363
3.

Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence.

Zuo Y, Rabinovich NE, Gilbert DG.

Psychopharmacology (Berl). 2017 Mar;234(5):761-771. doi: 10.1007/s00213-016-4509-1. Epub 2016 Dec 27.

PMID:
28028602
4.

Intra-individual changes in Stroop-related activations linked to cigarette abstinence in adolescent tobacco smokers: Preliminary findings.

Yip SW, Balodis IM, Carroll KM, Krishnan-Sarin S, Potenza MN.

Drug Alcohol Depend. 2016 Oct 1;167:182-9. doi: 10.1016/j.drugalcdep.2016.08.019. Epub 2016 Aug 21.

PMID:
27567966
5.

Adult attention-deficit/hyperactivity disorder and nicotine withdrawal: a qualitative study of patient perceptions.

Liebrenz M, Fisher CE, Nellen R, Frei A, Biechl AC, Hiestand N, Huber A, Buadze A, Eich D.

BMC Psychiatry. 2016 Jul 4;16:208. doi: 10.1186/s12888-016-0911-9.

6.

Examining Smoking Dependence Motives among African American Light Smokers.

Bronars CA, Faseru B, Krebill R, Mayo MS, Snow TM, Okuyemi KS, Ahluwalia JS, Cox LS.

J Smok Cessat. 2015 Dec 1;10(2):154-161. Epub 2014 Mar 26.

7.

Evaluating the Effects of Varenicline on Craving, Withdrawal, and Affect in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India.

Jhanjee S, Jain R, Jain V, Gupta T, Mittal S, Goelz P, Schnoll RA.

J Psychoactive Drugs. 2015 Sep-Oct;47(4):325-30. doi: 10.1080/02791072.2015.1075092. Epub 2015 Aug 28.

8.

Effects of the BDNF Val66Met Polymorphism on Anxiety-Like Behavior Following Nicotine Withdrawal in Mice.

Lee BG, Anastasia A, Hempstead BL, Lee FS, Blendy JA.

Nicotine Tob Res. 2015 Dec;17(12):1428-35. doi: 10.1093/ntr/ntv047. Epub 2015 Mar 5.

9.

Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.

Sarginson JE, Killen JD, Lazzeroni LC, Fortmann SP, Ryan HS, Ameli N, Schatzberg AF, Murphy GM Jr.

Nicotine Tob Res. 2015 Sep;17(9):1126-33. doi: 10.1093/ntr/ntu273. Epub 2015 Jan 8.

10.

ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice.

Yildirim E, Connor DA, Gould TJ.

Behav Pharmacol. 2015 Apr;26(3):241-8. doi: 10.1097/FBP.0000000000000111.

11.

Psychological symptoms, smoking lapse behavior, and the mediating effects of nicotine withdrawal symptoms: A laboratory study.

Ameringer KJ, Leventhal AM.

Psychol Addict Behav. 2015 Mar;29(1):71-81. doi: 10.1037/adb0000029. Epub 2014 Sep 22.

12.

Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies.

Simmons SJ, Gould TJ.

J Clin Pharm Ther. 2014 Oct;39(5):457-67. doi: 10.1111/jcpt.12171. Epub 2014 May 14. Review.

13.

Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.

Ashare RL, Schmidt HD.

Expert Opin Drug Discov. 2014 Jun;9(6):579-94. doi: 10.1517/17460441.2014.908180. Epub 2014 Apr 7. Review.

14.

Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors.

Yohn NL, Turner JR, Blendy JA.

J Pharmacol Exp Ther. 2014 May;349(2):348-54. doi: 10.1124/jpet.113.211706. Epub 2014 Mar 13.

15.

Cortisol levels decrease after acute tobacco abstinence in regular smokers.

Wong JA, Pickworth WB, Waters AJ, al'Absi M, Leventhal AM.

Hum Psychopharmacol. 2014 Mar;29(2):152-62.

16.

Patterns of change in affect and adrenocortical activity over an extended period of smoking abstinence.

Nakajima M, al'Absi M.

Psychol Addict Behav. 2013 Dec;27(4):1189-95. doi: 10.1037/a0033879. Epub 2013 Oct 14.

17.
18.

Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial.

Lofwall MR, Babalonis S, Nuzzo PA, Siegel A, Campbell C, Walsh SL.

Drug Alcohol Depend. 2013 Nov 1;133(1):188-97. doi: 10.1016/j.drugalcdep.2013.05.010. Epub 2013 Jun 4.

19.

A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia.

Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM.

Biol Psychiatry. 2013 Sep 15;74(6):436-43. doi: 10.1016/j.biopsych.2013.03.017. Epub 2013 May 6.

20.

Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment.

Ashare RL, Falcone M, Lerman C.

Neuropharmacology. 2014 Jan;76 Pt B:581-91. doi: 10.1016/j.neuropharm.2013.04.034. Epub 2013 Apr 29. Review.

Supplemental Content

Support Center